Prevalence of perennial severe allergic asthma in Italy and effectiveness of omalizumab in its management: PROXIMA – an observational, 2 phase, patient reported outcomes study

BACKGROUND: We designed the PROXIMA study (Patient-Reported Outcomes and Xolair(®) In the Management of Asthma) to determine the proportion of patients with severe asthma sensitive to perennial allergens, and to evaluate asthma control and treatment adherence up to 12 months in patients treated with...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Clin Mol Allergy
Autors principals: Canonica, Giorgio Walter, Bartezaghi, Marta, Marino, Raffaele, Rigoni, Laura
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2015
Matèries:
Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4494726/
https://ncbi.nlm.nih.gov/pubmed/26155196
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12948-015-0019-7
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars